Home Tags Boston Scientific

Tag: Boston Scientific

To provide a detailed look at the Reverse Osmosis and Nanofiltration Membrane market we have relied on it
The report, titled Interventional Oncology Market by Product (Embolization Devices, Ablation Devices)
Stents are miniaturized, flexible, or expandable tubular structures that are used to widen and create the patency of obstructed vascular or non-vascular tubular structures and ensure an even flow of body fluids through themNew York, Feb. 18, 2021 (GLOBE NEWSWIRE) - Reportlinkercom announces the publication of the "Stents Global Market - Forecast to 2027" report - https: // wwwreportlinkercom / p06025447 /? utm_source = GNW Compared to conventional highly invasive surgical repair methods, current minimally invasive transcatheter therapy methods with highly efficient, technologically advanced stent products ensure patients and healthcare providers improved efficiency, effectiveness and faster restoration of the narrowed vessels or natural function of the canal Increased use of the various stent products for the numerous and different types of vascular and non-vascular obstructive conditions and cerebral aneurysms in the patients, increasing the propensity of the value-oriented global patient pool to minimally invasive, technologically advanced stent products with better therapeutic outcomes and the need to understand the clinical manifestations associated with blocked vascular and non-vascular hollow organs or a weakened vascular bed are connected to quickly mitigate the Da Shortening the hospital stay and rapidly improving the patient's condition through efficient and safer interventional products is fueling the global stents market. The study estimates that the global stents market is expected to be 13Reaching $ 5228 million by 2027 will grow in the mid single digit CAGR range from 2020 to 2027 as various types of stenotic disease and cerebral aneurysms become more prevalent around the world and demand for highly efficient, minimally invasive therapeutic products from the value patient population increases The trend towards lowering the price of coronary stents and increasing the competitiveness of local players in some of the major APAC countries, a favorable reimbursement scenario in industrialized countries, the emergence of technologically advanced stent products, a persistently escalating geriatric population and the feasibility of even drug-eluting stents (DES) in them and the numerous acquisition and distribution agreements between the stent companies, the development of healthcare infrastructure facilities and the increasing demand for better healthcare services in emerging markets stents market is segmented by product, material, application, end user and geographic, based on the product is global Stents market divided into bare metal stents, drug eluting stents (DES), bioabsorbable stents, and other stents consisting of covered stents and non-drug eluting polymer stents n Among these products, the drug-eluting stents segment had the largest sales in 2020 and is expected to grow in the mid single digit CAGR range from 2020 to 2027 as the high-efficiency DES becomes more popular around the world and the technological and constant system continues to introduce technical improvements In these stent products, the bioresorbable stents segment is the fastest emerging segment and is expected to grow at a low CAGR in teenagers over the forecast period as research and development activities increase for the development of highly efficient and safe biodegradable stents that will be used after patency improvement of narrowed stents gradually disappearing vessel or ductBased on the materials used, the global stents market is divided into metal alloy-based stents and polymer-based stents, the metal alloy-based stents are w Further divided into stents made of cobalt-chromium alloys, stents made of nitinol or nickel-titanium alloys, stents made of platinum-chromium alloys, stents made of stainless steel and other stents made of metallic biomaterial such as magnesium, iron and others The polymer-based stents include stents that are made of permanent or bio-stable polymers and biodegradable polymers. In the overall material-based stents market, the metal alloy-based stents segment accounted for the largest share in 2020 and is due to the increasing use of various metallic materials in manufacturing of stents expected to grow in the mid-single-digit CAGR range from 2020 to 2027, bare metal stents (BMS), drug eluting stents (DES), covered stents and even the bioresorbable stents, as well as the display of the most desirable and beneficial stent properties such as high tensile or mechanical strength, elasticity, stiffness and Radiopacity of Metallic Biomaterials Amongst metal alloy-based stents, the segment of cobalt-chromium alloy stents had the largest sales in 2020 and is expected to grow in the mid-single-digit CAGR from 2020 to 2027, while the segment of nitinol alloy stents is the fastest growing Segment is and is expected to grow a mid single digit CAGR from 2020-2027 The polymer-based stents segment is the fastest growing segment growing at a high single digit CAGR from 2020 to 2027 This is due to the increasing use of polymers in the manufacture of DES, covered stents, polymeric non-drug-eluting stents, and polymeric bioresorbable stents, and the manifestation of stent beneficial properties such as flexibility, elasticity, and the controlled drug elution kinetics provided by the polymers among the various types of stents Polymer-based, the segment of permanent polymer-based stents had the largest revenue in 2020 and is expected to grow in the high single digit CAGR over the forecast period, while the segment of biodegradable polymer-based stents is the fastest growing segment of low teen CAGR from 2020 to 2027 based on According to the application, the global market for stents is roughly divided into vascular and non-vascular stents. Among these, the vascular stents segment had the highest sales in 2020 and is expected to be in the mid-range from 2020 to 2027 gene CAGR are growing as the prevalence of vascular stenotic conditions and cerebral aneurysm continues to increase worldwide worldwide various fast, efficient, technologically advanced and minimally traumatizing therapeutic interventions such as stenting The vascular stents are further divided into stents for coronary arteries, stents for peripheral arteries, neurovascular stents and other stents consisting of venous stents, vertebral artery stents, and pulmonary artery stents Among these, the coronary artery stents segment had the highest sales in 2020 and is expected to grow at a mid-single digit CAGR from 2020 to 2027, while the neurovascular stents segment is the is the fastest emerging segment and is expected to grow at a high single-digit CAGR from 2020 to 2027. Neurovascular stents can further be used in carotid stents, intracranial stents and flow diverter stents for the treatment of cerebral aneurysms kl Among the various neurovascular stents, stents from the carotid artery made up the largest turnover in 2020 and are expected to grow in the double-digit CAGR range between 2020 and 2027. Depending on the type of application, non-vascular stents are used in gastrointestinal stents, urinary tract stents or urological stents, respiratory or tracheobronchial stents or lung stents and other ophthalmic stents. Among these, the gastrointestinal (GI) stent segment achieved the highest sales in 2020 and is expected to grow in the low single-digit CAGR from 2020 to 2027. GI stents are further subdivided into pancreatic stents and biliary stents, colon or colorectal stents, esophageal stents, and duodenal stents Among these, the pancreatic & biliary stents segment had the largest sales in 2020 and is expected to grow in the mid single-digit CAGR from 2020 to 2027Based on end-users, the global market for stents is divided into hospitals Outpatient Surgery Centers (ASCs) and others consisting of free-standing or mobile catheterization laboratories and research institutes Among the various end-users, the Hospitals segment had the largest revenue in 2020 and is expected to grow in the low single-digit CAGR over the 2020-2027 period as different types of stent products for the stent procedures performed in stenting are increasingly used in hospital-related inpatient or outpatient settings The Ambulatory Surgery Centers (ASCs) segment is the fastest growing segment and is expected to grow in the mid-single-digit CAGR from 2020 to 2027.Based on the region, the global market for stents is North America (US. and rest of North America), Europe (Germany, France, Italy and rest of Europe), Asia Pacific (Japan, China, India and rest of APAC) and rest of the world (Brazil, Turkey, rest of Latin America and Middle East & Africa ) Most of the global stents market will be occupied by the Asia-Pacific region in 2020 and is expected to grow in the mid-single digit CAGR from 2020 to 2027, largely driven by the continued increase in prevalence of vascular and non-vascular stenotic conditions in the region Increasing the affordability and accessibility of key stent products, such as coronary stents, to the patients of some of the major countries in the region, due to government-imposed price-cutting measures on these life-saving devices, thereby affecting the geriatric population with different types of vessels or non-stented vascular obstructive Illnesses, increasing patient awareness and the demand for better, rapid, minimally invasive and efficient therapy methods with advanced therapeutic products, growing economies in the region, ongoing development of infrastructure facilities for the health care system in the region, increasing health expenditure and aspects of medical tourism in the region Rest of the World (ROW) is the fastest growing region and is expected to grow at a high single digit CAGR over the forecast period The Rapid Marketwac The growth rate of the stent market in this region is due to the increasing prevalence of obstructive conditions associated with vasculature and duct systems in the region, the increase in the geriatric population afflicted with various types of stenotic conditions, the increase in patient awareness and the demand for better, rapid, minimally invasive conditions therapeutic procedures and efficient therapeutic products, growing economies in the region, rising per capita spending on health needs, and prospects for medical tourism in the region The global market for stents is consolidating and few companies dominate and occupy a large one Market Share Some of the leading players in the stents market are Boston Scientific Corporation (US.), Abbott Laboratories (US.), Medtronic PLC (Ireland), Terumo Corporation (Japan), Cook Medical LLC (US.), Cardinal Health Inc (US.), Becton, Dickinson and Company (US.), B Braun Melsungen AG (Germany), Biotronik SE & CoKG (Germany), Blue Sail Medical Co Ltd (Biosensors International Pte Ltd) (China) and OthersThe report provides an in-depth market analysis of the above-mentioned segments in the following regions: • North Americao US.o Rest of North America • Europao Deutschlando Franceo Italyo Rest of Europe • Asia-Pacifico Chinao Japano Indiao Rest of APAC • Rest of the World (RoW) o Brazilo Turkeyo Rest of LATAM and Middle East and AfricaRead the full report: https: // wwwreportlinkercom / p06025447 /? utm_source = GNWAbout ReportlinkerReportLinker is an award-winning research solution Reportlinker finds and organizes the latest industry data so you can get all the research you need - instantly in one place __________________________ CONTACT: Clare: clare @ reportlinkercom US: (339) -368-6001 Intl: 1 339-368- 6001

Latest article

News – AU – NRL Trials 2021 LIVE Updates: Charity Shield tops a wide...

He's been the hottest property in both codes for the past 12 months, and Saturday is the day we get our first look at the Rooster Recruit Join us from 5pm

News – UK – World NGO Day 2021: date, history and meaning of International...

World NGO Day takes place on 27 February worldwide

News – GB – Riders Preview Pavé in the Omloop Het Nieuwsblad Training gallery

Alaphilippe, Gilbert, Van Avermaet and Van der Breggen are among the top drivers who are training in Belgium for the start of the Spring Classics